Pre-earnings options volume in Janux Therapeutics is normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move near 5.7%, or $2.28, after results are released. Median move over the past eight quarters is 6.8%.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JANX: